{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:43:50Z","timestamp":1792100630383,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2025C02071"],"award-info":[{"award-number":["2025C02071"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273132"],"award-info":[{"award-number":["82273132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403933"],"award-info":[{"award-number":["82403933"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017531","name":"Medical and Health Research Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2024KY065"],"award-info":[{"award-number":["2024KY065"]}],"id":[{"id":"10.13039\/501100017531","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.cellsig.2025.112054","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T23:13:10Z","timestamp":1754521990000},"page":"112054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["GLI2\/Parkin-mediated mitophagy promotes pazopanib resistance in clear cell renal cell carcinoma"],"prefix":"10.1016","volume":"135","author":[{"given":"Yiwei","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyou","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cellsig.2025.112054_bb0005","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jama.2024.12848","article-title":"Renal cell carcinoma: a review","volume":"332","author":"Rose","year":"2024","journal-title":"Jama-J Am. Med. Assoc."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112054_bb0010","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112054_bb0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","article-title":"Epidemiology of renal cell carcinoma: 2022 update","volume":"82","author":"Bukavina","year":"2022","journal-title":"Eur. Urol."},{"issue":"25","key":"10.1016\/j.cellsig.2025.112054_bb0020","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1200\/JCO.22.00868","article-title":"Management of metastatic clear cell renal cell carcinoma: ASCO guideline","volume":"40","author":"Rathmell","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112054_bb0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41585-022-00592-3","article-title":"Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma","volume":"19","author":"Ingels","year":"2022","journal-title":"Nat. Rev. Urol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112054_bb0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/oncolo\/oyab056","article-title":"First-line treatments for metastatic clear cell renal cell carcinoma: an ever-enlarging landscape","volume":"27","author":"Gulati","year":"2022","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112054_bb0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.eururo.2019.05.022","article-title":"Updated European Association of Urology guidelines on renal cell carcinoma: immune checkpoint inhibition is the new backbone in first-line treatment of metastatic clear-cell renal cell carcinoma","volume":"76","author":"Albiges","year":"2019","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112054_bb0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13046-021-01961-3","article-title":"Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma","volume":"40","author":"Sharma","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112054_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41585-022-00676-0","article-title":"Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma","volume":"20","author":"Rosellini","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.cellsig.2025.112054_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100929","article-title":"Sunitinib resistance in renal cell carcinoma: from molecular mechanisms to predictive biomarkers","volume":"67","author":"Jin","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112054_bb0055","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa1816714","article-title":"Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma","volume":"380","author":"Rini","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112054_bb0060","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa1816047","article-title":"Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma","volume":"380","author":"Motzer","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112054_bb0065","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","article-title":"The mitophagy pathway and its implications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112054_bb0070","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112054_bb0075","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1007\/s00018-021-03774-1","article-title":"Mitophagy in tumorigenesis and metastasis","volume":"78","author":"Poole","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112054_bb0080","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/s42255-023-00930-8","article-title":"Mitophagy in human health, ageing and disease","volume":"5","author":"Picca","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cellsig.2025.112054_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110631","article-title":"Parkin and mitochondrial signalling","volume":"106","author":"Connelly","year":"2023","journal-title":"Cell. Signal."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112054_bb0090","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1080\/15548627.2021.1975914","article-title":"The multifaceted regulation of mitophagy by endogenous metabolites","volume":"18","author":"Zhang","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.cellsig.2025.112054_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111329","article-title":"Mitochondrial signaling pathways and their role in cancer drug resistance","volume":"122","author":"Sharma","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cellsig.2025.112054_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102324","article-title":"Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells","volume":"53","author":"Rademaker","year":"2022","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112054_bb0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13046-023-02638-9","article-title":"METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy","volume":"42","author":"Sun","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.112054_bb0110","first-page":"0539","article-title":"STAT2\/SLC27A3\/PINK1-mediated mitophagy remodeling lipid metabolism contributes to pazopanib resistance in clear cell renal cell carcinoma","volume":"7","author":"Lu","year":"2024","journal-title":"Research (Wash D C)"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112054_bb0115","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.263556","article-title":"Counterregulatory roles of GLI2 and GLI3 in osteogenic differentiation via Gli1 expression","volume":"138","author":"Takahashi","year":"2025","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112054_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020147","article-title":"Gli proteins: regulation in development and cancer","volume":"8","author":"Niewiadomski","year":"2019","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.cellsig.2025.112054_bb0125","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41580-023-00591-1","article-title":"Cellular and molecular mechanisms of hedgehog signalling","volume":"24","author":"Zhang","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112054_bb0130","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1158\/0008-5472.CAN-22-2624","article-title":"Germline cancer gene expression quantitative trait loci are associated with local and global tumor mutations","volume":"83","author":"Liu","year":"2023","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.cellsig.2025.112054_bb0135","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41388-023-02883-4","article-title":"LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer via H3K4me1- and H3K27Ace-mediated GLI2 expression","volume":"43","author":"Chen","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2025.112054_bb0140","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbrc.2023.07.038","article-title":"The GLI2\/CDH6 axis enhances migration, invasion and mitochondrial fission of stomach adenocarcinoma cells","volume":"676","author":"Liu","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112054_bb0145","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.7150\/ijms.107228","article-title":"Nutraceutical evaluation of Trigonelline\u2019s therapeutic potential by targeting bladder cancer stem cells and cancer-associated fibroblasts via downregulation of TGFbeta3\/GLI2\/YAP1 signaling hub","volume":"22","author":"Kao","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.cellsig.2025.112054_bb0150","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.canlet.2020.10.031","article-title":"HOTAIR and androgen receptor synergistically increase GLI2 transcription to promote tumor angiogenesis and cancer stemness in renal cell carcinoma","volume":"498","author":"Bai","year":"2021","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112054_bb0155","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.arcmed.2019.08.010","article-title":"YAP promotes VEGFA expression and tumor angiogenesis though Gli2 in human renal cell carcinoma","volume":"50","author":"Xu","year":"2019","journal-title":"Arch. Med. Res."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112054_bb0160","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3892\/mco.2016.950","article-title":"GLI2 expression levels in radical nephrectomy specimens as a predictor of disease progression in patients with metastatic clear cell renal cell carcinoma following treatment with sunitinib","volume":"5","author":"Furukawa","year":"2016","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112054_bb0165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12967-024-05988-w","article-title":"miR-9-5p\/HMMR regulates the tumorigenesis and progression of clear cell renal cell carcinoma through EMT and JAK1\/STAT1 signaling pathway","volume":"23","author":"Niu","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cellsig.2025.112054_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114293","article-title":"A pH-dependent rhodamine fluorophore with antiproliferative activity of bladder cancer in vitro\/vivo and apoptosis mechanism","volume":"236","author":"Lu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112054_bb0175","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41419-021-04077-w","article-title":"KAT2A-mediated AR translocation into nucleus promotes abiraterone-resistance in castration-resistant prostate cancer","volume":"12","author":"Lu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2025.112054_bb0180","first-page":"0289","article-title":"Dissection of FOXO1-induced LYPLAL1-DT impeding triple-negative breast cancer progression via mediating hnRNPK\/beta-catenin complex","volume":"6","author":"Tang","year":"2023","journal-title":"Research (Wash D C)"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112054_bb0185","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1158\/0008-5472.CAN-22-2370","article-title":"PINK1-mediated mitophagy promotes oxidative phosphorylation and redox homeostasis to induce drug-tolerant persister cancer cells","volume":"83","author":"Li","year":"2023","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112054_bb0190","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41588-024-01662-5","article-title":"Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression","volume":"56","author":"Hu","year":"2024","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.cellsig.2025.112054_bb0195","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1073\/pnas.1909814117","article-title":"Decision between mitophagy and apoptosis by Parkin via VDAC1 ubiquitination","volume":"117","author":"Ham","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.cellsig.2025.112054_bb0200","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1080\/15548627.2020.1831815","article-title":"PRCC-TFE3 fusion-mediated PRKN\/parkin-dependent mitophagy promotes cell survival and proliferation in PRCC-TFE3 translocation renal cell carcinoma","volume":"17","author":"Wang","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.cellsig.2025.112054_bb0205","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.freeradbiomed.2024.10.272","article-title":"FUNDC1-mediated mitophagy regulates photodamage independently of the PINK1\/Parkin-dependent pathway","volume":"225","author":"He","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112054_bb0210","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1158\/0008-5472.CAN-22-3105","article-title":"ZDHHC2-mediated AGK palmitoylation activates AKT-mTOR signaling to reduce sunitinib sensitivity in renal cell carcinoma","volume":"83","author":"Sun","year":"2023","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112054_bb0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12943-022-01549-1","article-title":"N(6)-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma","volume":"21","author":"Chen","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2025.112054_bb0220","doi-asserted-by":"crossref","DOI":"10.1177\/15330338241274337","article-title":"Tumor-associated macrophage-derived TGF-beta1 activates GLI2 via the Smad2\/3 signaling pathway to affect cisplatin resistance in lung adenocarcinoma","volume":"23","author":"Lan","year":"2024","journal-title":"Technol. Cancer Res. Treat."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112054_bb0225","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1158\/0008-5472.CAN-24-1130","article-title":"GLI2 facilitates tumor immune evasion and immunotherapeutic resistance by coordinating WNT and prostaglandin signaling","volume":"85","author":"DeVito","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2025.112054_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107082","article-title":"Identification of Fasudil as a collaborator to promote the anti-tumor effect of lenvatinib in hepatocellular carcinoma by inhibiting GLI2-mediated hedgehog signaling pathway","volume":"200","author":"Huang","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cellsig.2025.112054_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.109952","article-title":"Beyond cyclopamine: targeting hedgehog signaling for cancer intervention","volume":"754","author":"Thazhackavayal Baby","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112054_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111016","article-title":"Hyperactivation of hedgehog signaling impedes myelin development and repair via cholesterol dysregulation in oligodendrocytes","volume":"27","author":"Fang","year":"2024","journal-title":"iScience"},{"issue":"15","key":"10.1016\/j.cellsig.2025.112054_bb0245","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.180582","article-title":"Targeting DRP1 with Mdivi-1 to correct mitochondrial abnormalities in ADOA+ syndrome","volume":"9","author":"Lin","year":"2024","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112054_bb0250","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.eururo.2022.10.010","article-title":"The 2022 updated European Association of Urology guidelines on the use of adjuvant immune checkpoint inhibitor therapy for renal cell carcinoma","volume":"83","author":"Bedke","year":"2023","journal-title":"Eur. Urol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825004693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825004693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:20:15Z","timestamp":1772810415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825004693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":50,"alternative-id":["S0898656825004693"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112054","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLI2\/Parkin-mediated mitophagy promotes pazopanib resistance in clear cell renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112054"}}